Entry |
|
Name |
Tanomastat (USAN/INN) |
Formula |
C23H19ClO3S
|
Exact mass |
410.0743
|
Mol weight |
410.91
|
Structure |

|
Efficacy |
Antineoplastic, Matrix metalloproteinase inhibitor |
Comment |
Treatment of osteoarthritis and in oncology
|
Target |
|
Pathway |
hsa04670 | Leukocyte transendothelial migration |
|
Brite |
Target-based classification of drugs [BR:br08310]
Peptidases and inhibitors
Metallo peptidases
Family M10
MMP1
D03802 Tanomastat (USAN/INN)
MMP2
D03802 Tanomastat (USAN/INN)
MMP9
D03802 Tanomastat (USAN/INN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 28
1 C8x C 19.4600 -17.3600
2 C8x C 19.4600 -18.7600
3 C8x C 20.6724 -19.4600
4 C8y C 21.8849 -18.7600
5 C8x C 21.8849 -17.3600
6 C8x C 20.6724 -16.6600
7 S2a S 23.1160 -19.4710
8 C1b C 24.3212 -18.7753
9 C1c C 25.5035 -19.4581
10 C1b C 26.6975 -18.7688
11 C6a C 25.5035 -20.8598
12 O6a O 24.2735 -21.5701
13 O6a O 26.6983 -21.5498
14 C5a C 27.8854 -19.4548
15 C8y C 29.0765 -18.7671
16 O5a O 27.8855 -20.8598
17 C8x C 30.2659 -19.4539
18 C8x C 31.4784 -18.7540
19 C8y C 31.4785 -17.3540
20 C8x C 30.2891 -16.6672
21 C8x C 29.0766 -17.3671
22 C8y C 32.7044 -16.6462
23 C8x C 33.9119 -17.3434
24 C8x C 35.1243 -16.6434
25 C8y C 35.1243 -15.2434
26 C8x C 33.9168 -14.5462
27 C8x C 32.7044 -15.2462
28 X Cl 36.3411 -14.5408
BOND 30
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 4 7 1
8 7 8 1
9 8 9 1
10 9 10 1
11 9 11 1 #Up
12 11 12 1
13 11 13 2
14 10 14 1
15 14 15 1
16 14 16 2
17 15 17 2
18 17 18 1
19 18 19 2
20 19 20 1
21 20 21 2
22 15 21 1
23 19 22 1
24 22 23 2
25 23 24 1
26 24 25 2
27 25 26 1
28 26 27 2
29 22 27 1
30 25 28 1
|